On Assignment (ASGN) has an average broker rating of 1.25, which is interpreted as a Strong Buy, as rated by 8 equity analysts. Nonetheless, 7 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. Nevertheless, the majority of 1 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold.
On Assignment (ASGN) has been rated by 6 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $47 and the lowest price target forecast is $41. The average forecast of all the analysts is $43.83 and the expected standard deviation is $2.14.
Shares of On Assignment Inc. appreciated by 4.42% during the last five trading days but lost 5.71% on a 4-week basis. On Assignment Inc. is up 0.26% in the last 3-month period. Year-to-Date the stock performance stands at -15.82%. On Assignment (NYSE:ASGN): stock turned positive on Tuesday. Though the stock opened at $37.61, the bulls momentum made the stock top out at $38.01 level for the day. The stock recorded a low of $37.61 and closed the trading day at $37.84, in the green by 1.18%. The total traded volume for the day was 174,422. The stock had closed at $37.4 in the previous days trading.
On Assignment, Inc. is a global provider of professionals in the information technology (IT), engineering and life sciences sectors. The Company matches people into positions for contract, contract-to-hire and direct hire assignments. Its operating segments include Apex, Oxford and Life Sciences Europe. The Apex Segment provides information technology and scientific staffing professionals for contract, contract-to-hire and permanent placement positions. The Oxford Segment provides contract and direct placement services of information technology and engineering professionals in specialized information technology, software and hardware engineering, and mechanical, electrical, validation and telecommunications engineering fields. The Life Sciences Europe Segment provides locally-based contract life science professionals to clients in the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical, automotive, educational and environmental industries.